Correlation Between Park Electrochemical and Apogee Therapeutics,

Can any of the company-specific risk be diversified away by investing in both Park Electrochemical and Apogee Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Park Electrochemical and Apogee Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Park Electrochemical and Apogee Therapeutics, Common, you can compare the effects of market volatilities on Park Electrochemical and Apogee Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Park Electrochemical with a short position of Apogee Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Park Electrochemical and Apogee Therapeutics,.

Diversification Opportunities for Park Electrochemical and Apogee Therapeutics,

-0.52

Correlation Coefficient

Park Electrochemical  Apogee Therapeutics,

Excellent diversification

The 3 months correlation between Park and Apogee is -0.52. Overlapping area represents the amount of risk that can be diversified away by holding Park Electrochemical and Apogee Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apogee Therapeutics, and Park Electrochemical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Park Electrochemical are associated (or correlated) with Apogee Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apogee Therapeutics, has no effect on the direction of Park Electrochemical i.e., Park Electrochemical and Apogee Therapeutics, go up and down completely randomly.

Pair Corralation between Park Electrochemical and Apogee Therapeutics,

Considering the 90-day investment horizon Park Electrochemical is expected to under-perform the Apogee Therapeutics,. But the stock apears to be less risky and, when comparing its historical volatility, Park Electrochemical is 1.97 times less risky than Apogee Therapeutics,. The stock trades about -0.13 of its potential returns per unit of risk. The Apogee Therapeutics, Common is currently generating about 0.03 of returns per unit of risk over similar time horizon. If you would invest  4,907  in Apogee Therapeutics, Common on October 10, 2024 and sell it today you would earn a total of  50.00  from holding Apogee Therapeutics, Common or generate 1.02% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	95.24%
Values	Daily Returns

Park Electrochemical  vs.  Apogee Therapeutics, Common

Park Electrochemical

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Park Electrochemical are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of rather unsteady forward-looking signals, Park Electrochemical may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Apogee Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Apogee Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound technical and fundamental indicators, Apogee Therapeutics, is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Park Electrochemical and Apogee Therapeutics,

The main advantage of trading using opposite Park Electrochemical and Apogee Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Park Electrochemical position performs unexpectedly, Apogee Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apogee Therapeutics, will offset losses from the drop in Apogee Therapeutics,'s long position.

The idea behind Park Electrochemical and Apogee Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.